ARK Genomic Revolution ETF (ARKG) — ()
Key Metrics
News
Cathie Wood Comeback: These 2 Ark ETFs are Sailing Higher Again
Published: by:
Sentiment: Positive ()
It's probably time to give Cathie Wood the benefit of the doubt as the tides turn back in disruptive innovation's favor.
Read More
Best-Performing ETFs of Last Week
Published: by:
Sentiment: Positive ()
Wall Street was upbeat last week, despite the release of hot January inflation data.
Read More
About ARK Genomic Revolution ETF ARKG
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. The companies held in ARKG may be leaders, enablers, or beneficiaries of technologies including: